AJTMH ASTMH Job Mart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 64(1_suppl), 2001, pp. 97-106
Copyright © 2001 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mendis, K
Right arrow Articles by Carter, R
Right arrow Search for Related Content
PubMed
Right arrow Articles by Mendis, K
Right arrow Articles by Carter, R

RESEARCH ARTICLES


The neglected burden of Plasmodium vivax malaria

K Mendis, BJ Sina, P Marchesini, AND R Carter
 
ABSTRACT

We estimate that the global burden of malaria due to Plasmodium vivax is approximately 70-80 million cases annually. Probably approximately 10-20% of the world's cases of P. vivax infection occur in Africa, south of the Sahara. In eastern and southern Africa, P. vivax represents around 10% of malaria cases but < 1% of cases in western and central Africa. Outside of African, P. vivax accounts for > 50% of all malaria cases. About 80-90% of P. vivax outside of Africa occurs in the Middle East, Asia, and the Western Pacific, mainly in the most tropical regions, and 10-15% in Central and South America. Because malaria transmission rates are low in most regions where P. vivax is prevalent, the human populations affected achieve little immunity to this parasite; as a result, in these regions, P. vivax infections affect people of all ages. Although the effects of repeated attacks of P. vivax through childhood and adult life are only rarely directly lethal, they can have major deleterious effects on personal well-being, growth, and development, and on the economic performance at the individual, family, community, and national levels. Features of the transmission biology of P. vivax give this species greater resilience than the less robust Plasmodiumfalciparum in the face of conditions adverse to the transmission of the parasites. Therefore, as control measures become more effective, the residual malaria burden is likely increasingly to become that of P. vivax.




This article has been cited by other articles:


Home page
 Clin. Microbiol. Rev.Home page
P. Schlagenhauf and E. Petersen
Malaria Chemoprophylaxis: Strategies for Risk Groups
Clin. Microbiol. Rev., July 1, 2008; 21(3): 466 - 472.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
U. Lek-Uthai, R. Suwanarusk, R. Ruengweerayut, T. S. Skinner-Adams, F. Nosten, D. L. Gardiner, P. Boonma, K. A. Piera, K. T. Andrews, B. MacHunter, et al.
Stronger Activity of Human Immunodeficiency Virus Type 1 Protease Inhibitors against Clinical Isolates of Plasmodium vivax than against Those of P. falciparum
Antimicrob. Agents Chemother., July 1, 2008; 52(7): 2435 - 2441.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. A. Siddiqui, H. Bora, N. Singh, A. P. Dash, and Y. D. Sharma
Expression, Purification, and Characterization of the Immunological Response to a 40-Kilodalton Plasmodium vivax Tryptophan-Rich Antigen
Infect. Immun., June 1, 2008; 76(6): 2576 - 2586.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
S. Krudsood, N. Tangpukdee, P. Wilairatana, N. Phophak, J. K. Baird, G. M. Brittenham, and S. Looareesuwan
High-dose Primaquine Regimens against Relapse of Plasmodium vivax Malaria
Am J Trop Med Hyg, May 1, 2008; 78(5): 736 - 740.
[Abstract] [Full Text] [PDF]

Home page
 J Trop PediatrHome page
A. J. Rodriguez-Morales, J. A. Benitez, and M. Arria
Malaria Mortality in Venezuela: Focus on Deaths due to Plasmodium vivax in Children
J Trop Pediatr, April 1, 2008; 54(2): 94 - 101.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
A. Kumar, N. Valecha, T. Jain, and A. P. Dash
Burden of Malaria in India: Retrospective and Prospective View
Am J Trop Med Hyg, December 1, 2007; 77(6_Suppl): 69 - 78.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
R. N. Price, E. Tjitra, C. A. Guerra, S. Yeung, N. J. White, and N. M. Anstey
Vivax Malaria: Neglected and Not Benign
Am J Trop Med Hyg, December 1, 2007; 77(6_Suppl): 79 - 87.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
C. Guinovart and P. L. Alonso
Methods for Determining Vaccine Efficacy and Effectiveness and the Main Barriers to Developing a Fully Deployable Malaria Vaccine
Am J Trop Med Hyg, December 1, 2007; 77(6_Suppl): 276 - 281.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
J. L. Cole-Tobian, P. Michon, E. Dabod, I. Mueller, and C. L. King
Dynamics of Asymptomatic Plasmodium vivax Infections and Duffy Binding Protein Polymorphisms in Relation to Parasitemia Levels in Papua New Guinean Children
Am J Trop Med Hyg, November 1, 2007; 77(5): 955 - 962.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
C. R. Lesko, P. M. Arguin, and R. D. Newman
Congenital Malaria in the United States: A Review of Cases From 1966 to 2005
Arch Pediatr Adolesc Med, November 1, 2007; 161(11): 1062 - 1067.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. D. Edstein, B. M. Kotecka, A. L. Ager, K. S. Smith, C. A. DiTusa, D. S. Diaz, D. E. Kyle, G. A. Schiehser, D. P. Jacobus, K. H. Rieckmann, et al.
Antimalarial pharmacodynamics and pharmacokinetics of a third-generation antifolate JPC2056 in cynomolgus monkeys using an in vivo in vitro model
J. Antimicrob. Chemother., October 1, 2007; 60(4): 811 - 818.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
M. S. Bastos, M. da Silva-Nunes, R. S. Malafronte, E. H. E. Hoffmann, G. Wunderlich, S. L. Moraes, and M. U. Ferreira
Antigenic Polymorphism and Naturally Acquired Antibodies to Plasmodium vivax Merozoite Surface Protein 1 in Rural Amazonians
Clin. Vaccine Immunol., October 1, 2007; 14(10): 1249 - 1259.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
P. Druilhe, P. Brasseur, C. Blanc, and M. Makler
Improved Assessment of Plasmodium vivax Response to Antimalarial Drugs by a Colorimetric Double-Site Plasmodium Lactate Dehydrogenase Antigen Capture Enzyme-Linked Immunosorbent Assay
Antimicrob. Agents Chemother., June 1, 2007; 51(6): 2112 - 2116.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
S.-H. Kim, S.-Y. Hwang, Y.-S. Lee, I.-H. Choi, S.-G. Park, and W.-G. Kho
Single-Chain Antibody Fragment Specific for Plasmodium vivax Duffy Binding Protein
Clin. Vaccine Immunol., June 1, 2007; 14(6): 726 - 731.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
K. RUNGSIHIRUNRAT, K. NA-BANGCHANG, V. N. HAWKINS, M. MUNGTHIN, and C. H. SIBLEY
SENSITIVITY TO ANTIFOLATES AND GENETIC ANALYSIS OF PLASMODIUM VIVAX ISOLATES FROM THAILAND
Am J Trop Med Hyg, June 1, 2007; 76(6): 1057 - 1065.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
T. Leslie, M. I. Mayan, M. A. Hasan, M. H. Safi, E. Klinkenberg, C. J. M. Whitty, and M. Rowland
Sulfadoxine-Pyrimethamine, Chlorproguanil-Dapsone, or Chloroquine for the Treatment of Plasmodium vivax Malaria in Afghanistan and Pakistan: A Randomized Controlled Trial
JAMA, May 23, 2007; 297(20): 2201 - 2209.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
L. H. Chen, M. E. Wilson, and P. Schlagenhauf
Controversies and Misconceptions in Malaria Chemoprophylaxis for Travelers
JAMA, May 23, 2007; 297(20): 2251 - 2263.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
K. S. Griffith, L. S. Lewis, S. Mali, and M. E. Parise
Treatment of Malaria in the United States: A Systematic Review
JAMA, May 23, 2007; 297(20): 2264 - 2277.
[Abstract] [Full Text] [PDF]

Home page
 Mol Biol EvolHome page
A. M. Gunasekera, T. Wickramarachchi, D. E. Neafsey, I. Ganguli, L. Perera, P. H. Premaratne, D. Hartl, S. M. Handunnetti, P. V. Udagama-Randeniya, and D. F. Wirth
Genetic Diversity and Selection at the Plasmodium vivax Apical Membrane Antigen-1 (PvAMA-1) Locus in a Sri Lankan Population
Mol. Biol. Evol., April 1, 2007; 24(4): 939 - 947.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
J. K. BAIRD
A RARE GLIMPSE AT THE EFFICACY OF PRIMAQUINE
Am J Trop Med Hyg, February 1, 2007; 76(2): 201 - 202.
[Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
J. L. GOLLER, D. JOLLEY, P. RINGWALD, and B.-A. BIGGS
REGIONAL DIFFERENCES IN THE RESPONSE OF PLASMODIUM VIVAX MALARIA TO PRIMAQUINE AS ANTI-RELAPSE THERAPY
Am J Trop Med Hyg, February 1, 2007; 76(2): 203 - 207.
[Abstract] [Full Text] [PDF]

Home page
 J Clin PharmacolHome page
J. P. Daily
Antimalarial drug therapy: the role of parasite biology and drug resistance.
J. Clin. Pharmacol., December 1, 2006; 46(12): 1487 - 1497.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
J. A. BONILLA, L. VALIDUM, R. CUMMINGS, and C. J. PALMER
GENETIC DIVERSITY OF PLASMODIUM VIVAX PVCSP AND PVMSP1 IN GUYANA, SOUTH AMERICA
Am J Trop Med Hyg, November 1, 2006; 75(5): 830 - 835.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
G. ALVAREZ, J.-G. PINEROS, A. TOBON, A. RIOS, A. MAESTRE, S. BLAIR, and J. CARMONA-FONSECA
Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia.
Am J Trop Med Hyg, October 1, 2006; 75(4): 605 - 609.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
A. R. BHARTI, R. CHUQUIYAURI, K. C. BROUWER, J. STANCIL, J. LIN, A. LLANOS-CUENTAS, and J. M. VINETZ
Experimental infection of the neotropical malaria vector anopheles darlingi by human patient-derived Plasmodium vivax in the peruvian Amazon.
Am J Trop Med Hyg, October 1, 2006; 75(4): 610 - 616.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
A. AULIFF, D. W. WILSON, B. RUSSELL, Q. GAO, N. CHEN, L. N. ANH, J. MAGUIRE, D. BELL, M. T. O'NEIL, and Q. CHENG
AMINO ACID MUTATIONS IN PLASMODIUM VIVAX DHFR AND DHPS FROM SEVERAL GEOGRAPHICAL REGIONS AND SUSCEPTIBILITY TO ANTIFOLATE DRUGS.
Am J Trop Med Hyg, October 1, 2006; 75(4): 617 - 621.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
J. SOTO, J. TOLEDO, M. LUZZ, P. GUTIERREZ, J. BERMAN, and S. DUPARC
Randomized, double-blind, placebo-controlled study of malarone for malaria prophylaxis in non-immune colombian soldiers.
Am J Trop Med Hyg, September 1, 2006; 75(3): 430 - 433.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
S. ZAKERI, A. A. MEHRIZI, S. MAMAGHANI, S. NOORIZADEH, G. SNOUNOU, and N. D. DJADID
POPULATION STRUCTURE ANALYSIS OF PLASMODIUM VIVAX IN AREAS OF IRAN WITH DIFFERENT MALARIA ENDEMICITY.
Am J Trop Med Hyg, March 1, 2006; 74(3): 394 - 400.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
R. CARTER and K. MENDIS
MEASURING MALARIA
Am J Trop Med Hyg, February 1, 2006; 74(2): 187 - 188.
[Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
R. W. SNOW and S. I. HAY
COMPARING METHODS OF ESTIMATING THE GLOBAL MORBIDITY BURDEN FROM PLASMODIUM FALCIPARUM MALARIA
Am J Trop Med Hyg, February 1, 2006; 74(2): 189 - 190.
[Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
E. S. HIGGS and B. SINA
PLASMODIUM VIVAX VACCINE RESEARCH: STEPS IN THE RIGHT DIRECTION
Am J Trop Med Hyg, November 1, 2005; 73(5_suppl): 1 - 2.
[Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
S. HERRERA, A. BONELO, B. L. PERLAZA, O. L. FERNANDEZ, L. VICTORIA, A. M. LENIS, L. SOTO, H. HURTADO, L. M. ACUNA, J. D. VELEZ, et al.
SAFETY AND ELICITATION OF HUMORAL AND CELLULAR RESPONSES IN COLOMBIAN MALARIA-NAIVE VOLUNTEERS BY A PLASMODIUM VIVAX CIRCUMSPOROZOITE PROTEIN-DERIVED SYNTHETIC VACCINE
Am J Trop Med Hyg, November 1, 2005; 73(5_suppl): 3 - 9.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
A. JORDAN-VILLEGAS, J. C. ZAPATA, A. B. PERDOMO, G. E. QUINTERO, Y. SOLARTE, M. AREVALO-HERRERA, and S. HERRERA
AOTUS LEMURINUS GRISEIMEMBRA MONKEYS: A SUITABLE MODEL FOR PLASMODIUM VIVAX SPOROZOITE INFECTION
Am J Trop Med Hyg, November 1, 2005; 73(5_suppl): 10 - 15.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
A. VALDERRAMA-AGUIRRE, G. QUINTERO, A. GOMEZ, A. CASTELLANOS, Y. PEREZ, F. MENDEZ, M. AREVALO-HERRERA, and S. HERRERA
ANTIGENICITY, IMMUNOGENICITY, AND PROTECTIVE EFFICACY OF PLASMODIUM VIVAX MSP1 PV200L: A POTENTIAL MALARIA VACCINE SUBUNIT
Am J Trop Med Hyg, November 1, 2005; 73(5_suppl): 16 - 24.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
M. AREVALO-HERRERA, A. CASTELLANOS, S. S. YAZDANI, A. R. SHAKRI, C. E. CHITNIS, R. DOMINIK, and S. HERRERA
IMMUNOGENICITY AND PROTECTIVE EFFICACY OF RECOMBINANT VACCINE BASED ON THE RECEPTOR-BINDING DOMAIN OF THE PLASMODIUM VIVAX DUFFY BINDING PROTEIN IN AOTUS MONKEYS
Am J Trop Med Hyg, November 1, 2005; 73(5_suppl): 25 - 31.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
M. AREVALO-HERRERA, Y. SOLARTE, M. F. YASNOT, A. CASTELLANOS, A. RINCON, A. SAUL, J. MU, C. LONG, L. MILLER, and S. HERRERA
INDUCTION OF TRANSMISSION-BLOCKING IMMUNITY IN AOTUS MONKEYS BY VACCINATION WITH A PLASMODIUM VIVAX CLINICAL GRADE PVS25 RECOMBINANT PROTEIN
Am J Trop Med Hyg, November 1, 2005; 73(5_suppl): 32 - 37.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
M. AREVALO-HERRERA, Y. SOLARTE, F. ZAMORA, F. MENDEZ, M. F. YASNOT, L. ROCHA, C. LONG, L. H. MILLER, and S. HERRERA
PLASMODIUM VIVAX: TRANSMISSION-BLOCKING IMMUNITY IN A MALARIA-ENDEMIC AREA OF COLOMBIA
Am J Trop Med Hyg, November 1, 2005; 73(5_suppl): 38 - 43.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
S. HERRERA, A. GOMEZ, O. VERA, J. VERGARA, A. VALDERRAMA-AGUIRRE, A. MAESTRE, F. MENDEZ, R. WANG, C. E. CHITNIS, S. S. YAZDANI, et al.
ANTIBODY RESPONSE TO PLASMODIUM VIVAX ANTIGENS IN FY-NEGATIVE INDIVIDUALS FROM THE COLOMBIAN PACIFIC COAST
Am J Trop Med Hyg, November 1, 2005; 73(5_suppl): 44 - 49.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P. Kongsaeree, P. Khongsuk, U. Leartsakulpanich, P. Chitnumsub, B. Tarnchompoo, M. D. Walkinshaw, and Y. Yuthavong
Crystal structure of dihydrofolate reductase from Plasmodium vivax: Pyrimethamine displacement linked with mutation-induced resistance
PNAS, September 13, 2005; 102(37): 13046 - 13051.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
J. L. COLE-TOBIAN, M. BIASOR, and C. L. KING
HIGH COMPLEXITY OF PLASMODIUM VIVAX INFECTIONS IN PAPUA NEW GUINEAN CHILDREN
Am J Trop Med Hyg, September 1, 2005; 73(3): 626 - 633.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
T. M. TRAN, J. OLIVEIRA-FERREIRA, A. MORENO, F. SANTOS, S. S. YAZDANI, C. E. CHITNIS, J. D. ALTMAN, E. V-S. MEYER, J. W. BARNWELL, and M. R. GALINSKI
COMPARISON OF IgG REACTIVITIES TO PLASMODIUM VIVAX MEROZOITE INVASION ANTIGENS IN A BRAZILIAN AMAZON POPULATION
Am J Trop Med Hyg, August 1, 2005; 73(2): 244 - 255.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
J. C. RAYNER, T. M. TRAN, V. CORREDOR, C. S. HUBER, J. W. BARNWELL, and M. R. GALINSKI
DRAMATIC DIFFERENCE IN DIVERSITY BETWEEN PLASMODIUM FALCIPARUM AND PLASMODIUM VIVAX RETICULOCYTE BINDING-LIKE GENES
Am J Trop Med Hyg, June 1, 2005; 72(6): 666 - 674.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
I. P. CERAVOLO, O. BRUNA-ROMERO, E. M. BRAGA, C. J. F. FONTES, C. F. A. BRITO, J. M. SOUZA, A. U. KRETTLI, J. H. ADAMS, and L. H. CARVALHO
ANTI-PLASMODIUM VIVAX DUFFY BINDING PROTEIN ANTIBODIES MEASURE EXPOSURE TO MALARIA IN THE BRAZILIAN AMAZON
Am J Trop Med Hyg, June 1, 2005; 72(6): 675 - 681.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. K. Baird
Effectiveness of Antimalarial Drugs
N. Engl. J. Med., April 14, 2005; 352(15): 1565 - 1577.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. A. Escalante, O. E. Cornejo, D. E. Freeland, A. C. Poe, E. Durrego, W. E. Collins, and A. A. Lal
A monkey's tale: The origin of Plasmodium vivax as a human malaria parasite
PNAS, February 8, 2005; 102(6): 1980 - 1985.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
M. D. Hastings, J. D. Maguire, M. J. Bangs, P. A. Zimmerman, J. C. Reeder, J. K. Baird, and C. H. Sibley
Novel Plasmodium vivax dhfr Alleles from the Indonesian Archipelago and Papua New Guinea: Association with Pyrimethamine Resistance Determined by a Saccharomyces cerevisiae Expression System
Antimicrob. Agents Chemother., February 1, 2005; 49(2): 733 - 740.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
J. M. Spudick, L. S. Garcia, D. M. Graham, and D. A. Haake
Diagnostic and Therapeutic Pitfalls Associated with Primaquine-Tolerant Plasmodium vivax
J. Clin. Microbiol., February 1, 2005; 43(2): 978 - 981.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
E.-T. HAN, T.-E. SONG, J.-H. PARK, E.-H. SHIN, S.-M. GUK, T.-Y. KIM, and J.-Y. CHAI
ALLELIC DIMORPHISM IN THE MEROZOITE SURFACE PROTEIN-3{alpha} IN KOREAN ISOLATES OF PLASMODIUM VIVAX
Am J Trop Med Hyg, December 1, 2004; 71(6): 745 - 749.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. M. VanBuskirk, E. Sevova, and J. H. Adams
Conserved residues in the Plasmodium vivax Duffy-binding protein ligand domain are critical for erythrocyte receptor recognition
PNAS, November 2, 2004; 101(44): 15754 - 15759.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
M. U. Ferreira, M. da Silva Nunes, and G. Wunderlich
Antigenic Diversity and Immune Evasion by Malaria Parasites
Clin. Vaccine Immunol., November 1, 2004; 11(6): 987 - 995.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. C. Leclerc, P. Durand, C. Gauthier, S. Patot, N. Billotte, M. Menegon, C. Severini, F. J. Ayala, and F. Renaud
From The Cover: Meager genetic variability of the human malaria agent Plasmodium vivax
PNAS, October 5, 2004; 101(40): 14455 - 14460.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. Brega, F. de Monbrison, C. Severini, R. Udomsangpetch, I. Sutanto, P. Ruckert, F. Peyron, and S. Picot
Real-Time PCR for Dihydrofolate Reductase Gene Single-Nucleotide Polymorphisms in Plasmodium vivax Isolates
Antimicrob. Agents Chemother., July 1, 2004; 48(7): 2581 - 2587.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
J. SATTABONGKOT, T. TSUBOI, H. HISAEDA, M. TACHIBANA, N. SUWANABUN, T. RUNGRUANG, Y.-M. CAO, A. W. STOWERS, J. SIRICHAISINTHOP, R. E. COLEMAN, et al.
BLOCKING OF TRANSMISSION TO MOSQUITOES BY ANTIBODY TO PLASMODIUM VIVAX MALARIA VACCINE CANDIDATES PVS25 AND PVS28 DESPITE ANTIGENIC POLYMORPHISM IN FIELD ISOLATES
Am J Trop Med Hyg, November 1, 2003; 69(5): 536 - 541.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
J. C. GOMEZ, D. T. MCNAMARA, M. J. BOCKARIE, J. K. BAIRD, J. M. CARLTON, and P. A. ZIMMERMAN
IDENTIFICATION OF A POLYMORPHIC PLASMODIUM VIVAX MICROSATELLITE MARKER
Am J Trop Med Hyg, October 1, 2003; 69(4): 377 - 379.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
X. Feng, J. M. Carlton, D. A. Joy, J. Mu, T. Furuya, B. B. Suh, Y. Wang, J. W. Barnwell, and X.-Z. Su
Single-nucleotide polymorphisms and genome diversity in Plasmodium vivax
PNAS, July 8, 2003; 100(14): 8502 - 8507.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
J. Xainli, J. L. Cole-Tobian, M. Baisor, W. Kastens, M. Bockarie, S. S. Yazdani, C. E. Chitnis, J. H. Adams, and C. L. King
Epitope-Specific Humoral Immunity to Plasmodium vivax Duffy Binding Protein
Infect. Immun., May 1, 2003; 71(5): 2508 - 2515.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
L. CUI, C. N. MASCORRO, Q. FAN, K. A. RZOMP, B. KHUNTIRAT, G. ZHOU, H. CHEN, G. YAN, and J. SATTABONGKOT
GENETIC DIVERSITY AND MULTIPLE INFECTIONS OF PLASMODIUM VIVAX MALARIA IN WESTERN THAILAND
Am J Trop Med Hyg, May 1, 2003; 68(5): 613 - 619.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
R. W. Steketee
Pregnancy, Nutrition and Parasitic Diseases
J. Nutr., May 1, 2003; 133(5): 1661S - 1667.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
E. D. MANGONI, C. SEVERINI, M. MENEGON, R. ROMI, G. RUGGIERO, and G. MAJORI
CASE REPORT: AN UNUSUAL LATE RELAPSE OF PLASMODIUM VIVAX MALARIA
Am J Trop Med Hyg, February 1, 2003; 68(2): 159 - 160.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
B. M. Russell, R. Udomsangpetch, K. H. Rieckmann, B. M. Kotecka, R. E. Coleman, and J. Sattabongkot
Simple In Vitro Assay for Determining the Sensitivity of Plasmodium vivax Isolates from Fresh Human Blood to Antimalarials in Areas where P. vivax Is Endemic
Antimicrob. Agents Chemother., January 1, 2003; 47(1): 170 - 173.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. Putaporntip, S. Jongwutiwes, N. Sakihama, M. U. Ferreira, W.-G. Kho, A. Kaneko, H. Kanbara, T. Hattori, and K. Tanabe
Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus
PNAS, December 10, 2002; 99(25): 16348 - 16353.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. G. Ridley
Chemotherapeutic hope on the horizon for Plasmodium vivax malaria?
PNAS, October 15, 2002; 99(21): 13362 - 13364.
[Full Text] [PDF]